Concordance for Islet Autoimmunity among Monozygotic Twins
New England Journal of Medicine (Impact Factor: 54.42). 01/2009; 359(26):2849-50. DOI: 10.1056/NEJMc0805398
[Show abstract] [Hide abstract]
ABSTRACT: Type 1 diabetes (T1D) is a chronic autoimmune disorder resulting from immune-mediated destruction of insulin-producing beta cells within the pancreatic islets. Prediction of T1D is now possible, as having 2 or more islet autoantibodies confers a 100% risk of diabetes development. With the ability to predict disease development, clinical trials to prevent diabetes onset have been completed and are currently under way. This review focuses on the natural history, prediction, and prevention trials in T1D. We review the lessons learned from these attempts at preventing a chronic autoimmune disease and apply the paradigm from T1D prevention to other autoimmune disorders. Copyright © 2014 Elsevier Inc. All rights reserved.Rheumatic Disease Clinics of North America 09/2014; 40(4). DOI:10.1016/j.rdc.2014.07.008 · 1.74 Impact Factor
Diabetes 11/2014; 63(11):3581-3. DOI:10.2337/db14-0824 · 8.47 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.